You appear to be offline. Some data may be unavailable until your connection is restored.
BSX
StockBoston Scientific Corp
Price data not available
Description
Boston Scientific Corp. develops, manufactures and markets a broad portfolio of minimally invasive medical devices used in specialties such as interventional cardiology, electrophysiology, peripheral vascular interventions, endoscopy, urology, pelvic health and neuromodulation. The company operates within the global medical‑technology sector, selling its products directly and through distributors to hospitals, clinics and ambulatory surgery centers in roughly 130 countries. It is recognized as one of the world’s largest medical‑device manufacturers and a market leader in several therapeutic areas, notably cardiovascular and endosurgery solutions. Boston Scientific’s business model focuses on innovation, regulatory approval and partnerships to expand its product pipeline and maintain a competitive position against other major device firms.
Quarterly EarningsQuarterly earnings results, including reported and estimated earnings per share (EPS), for the most recent fiscal quarters.Surprise compares reported EPS with the prior estimate.
| Quarter | DateReport date | EPSReported EPS |
|---|---|---|
| Q4 FY26 | Jan 27, 2027 (est.) | — |
| Q3 FY26 | Oct 28, 2026 | $0.73 |
| Q2 FY26 | Jul 29, 2026 | $0.86 |
| Q1 FY26 | Apr 22, 2026 | $0.80 |
| Q4 FY25 | Feb 4, 2026 | $0.80 |
Stay ahead of BSX earnings
Get reminders ahead of BSX's next earnings report, so you always know when results are coming.